FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2007144923> ?p ?o ?g. }

• W2007144923 endingPage "955" @default.
• W2007144923 startingPage "944" @default.
• W2007144923 abstract "Background aims Adipose tissue (AT)-derived mesenchymal stromal cells (MSC) (AT-MSC) represent a novel tool for delivering therapeutic genes to tumor cells. Interferon (IFN)-β is a cytokine with pleiotropic cellular functions, including anti-proliferative, immunomodulatory and anti-angiogenic activities. The purpose of this study was to engineer canine AT-MSC (cAT-MSC) producing IFN-β and to evaluate the anti-tumor effect of cAT-MSC–IFN-β combined with cisplatin in mouse melanoma model Methods cAT-MSC engineered to express mouse IFN-β were generated using a lentiviral vector (cAT-MSC–IFN-β) and the secreted IFN-β-induced inhibition of tumor cell growth and apoptosis on B16F10 cells was investigated in vitro prior to in vivo studies. Melanoma-bearing mouse was developed by injecting B16F10 cells subcutaneously into 6-week-old C57BL/6 mice. After 14 days, cisplatin (10 mg/kg) was injected intratumorally, and 3 days later the engineered cAT-MSC were injected subcutaneously every 3 days to death. Tumor volume and survival times were measured Results The combination treatment of cAT-MSC–IFN-β with cisplatin was more effective in inhibiting the growth of melanoma and resulted in significantly extended survival time than both an unengineered cAT-MSC–cisplatin combination group and a cisplatin-alone group. Interestingly, subcutaneously injected cAT-MSC–IFN-β were migrated to tumor sites Conclusions Our data suggest that canine AT-MSC could serve as a powerful cell-based delivery vehicle for releasing therapeutic proteins to tumor lesions. Maximal anti-tumor effects were seen when this therapy was combined with a DNA-damaging chemotherapeutic agent. This study demonstrates the possible applicability of AT-MSC-mediated IFN-β in treating canine and human cancer patients." @default.
• W2007144923 created "2016-06-24" @default.
• W2007144923 creator A5000251765 @default.
• W2007144923 creator A5001563760 @default.
• W2007144923 creator A5011398254 @default.
• W2007144923 creator A5013165857 @default.
• W2007144923 creator A5024860849 @default.
• W2007144923 creator A5028807480 @default.
• W2007144923 creator A5033864294 @default.
• W2007144923 creator A5040136102 @default.
• W2007144923 date "2011-09-01" @default.
• W2007144923 modified "2023-10-16" @default.
• W2007144923 title "Anti-tumor effects of canine adipose tissue-derived mesenchymal stromal cell-based interferon-β gene therapy and cisplatin in a mouse melanoma model" @default.
• W2007144923 cites W1493780140 @default.
• W2007144923 cites W159061167 @default.
• W2007144923 cites W1929485758 @default.
• W2007144923 cites W1931577828 @default.
• W2007144923 cites W1978375745 @default.
• W2007144923 cites W1984583580 @default.
• W2007144923 cites W1990448308 @default.
• W2007144923 cites W1994543822 @default.
• W2007144923 cites W1995499825 @default.
• W2007144923 cites W2003559866 @default.
• W2007144923 cites W2004718750 @default.
• W2007144923 cites W2007098561 @default.
• W2007144923 cites W2011832231 @default.
• W2007144923 cites W2017969565 @default.
• W2007144923 cites W2020794309 @default.
• W2007144923 cites W2025235666 @default.
• W2007144923 cites W2030480905 @default.
• W2007144923 cites W2031812779 @default.
• W2007144923 cites W2034269086 @default.
• W2007144923 cites W2036348189 @default.
• W2007144923 cites W2040587518 @default.
• W2007144923 cites W2047003816 @default.
• W2007144923 cites W2051748521 @default.
• W2007144923 cites W2053829861 @default.
• W2007144923 cites W2062875878 @default.
• W2007144923 cites W2064393764 @default.
• W2007144923 cites W2064919073 @default.
• W2007144923 cites W2065902307 @default.
• W2007144923 cites W2078118513 @default.
• W2007144923 cites W2078197760 @default.
• W2007144923 cites W2085216114 @default.
• W2007144923 cites W2085546686 @default.
• W2007144923 cites W2087353148 @default.
• W2007144923 cites W2093817631 @default.
• W2007144923 cites W2095666785 @default.
• W2007144923 cites W2099205356 @default.
• W2007144923 cites W2103565638 @default.
• W2007144923 cites W2117994949 @default.
• W2007144923 cites W2125793635 @default.
• W2007144923 cites W2127734192 @default.
• W2007144923 cites W2132757216 @default.
• W2007144923 cites W2143022774 @default.
• W2007144923 cites W2143516374 @default.
• W2007144923 cites W2148278891 @default.
• W2007144923 cites W2149685956 @default.
• W2007144923 cites W2150263441 @default.
• W2007144923 cites W2154024950 @default.
• W2007144923 cites W2159160080 @default.
• W2007144923 cites W2159614234 @default.
• W2007144923 cites W2163234891 @default.
• W2007144923 cites W2314203153 @default.
• W2007144923 cites W2952165521 @default.
• W2007144923 doi "https://doi.org/10.3109/14653249.2011.584864" @default.
• W2007144923 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21846298" @default.
• W2007144923 hasPublicationYear "2011" @default.
• W2007144923 type Work @default.
• W2007144923 sameAs 2007144923 @default.
• W2007144923 citedByCount "37" @default.
• W2007144923 countsByYear W20071449232012 @default.
• W2007144923 countsByYear W20071449232013 @default.
• W2007144923 countsByYear W20071449232014 @default.
• W2007144923 countsByYear W20071449232015 @default.
• W2007144923 countsByYear W20071449232016 @default.
• W2007144923 countsByYear W20071449232017 @default.
• W2007144923 countsByYear W20071449232018 @default.
• W2007144923 countsByYear W20071449232019 @default.
• W2007144923 countsByYear W20071449232020 @default.
• W2007144923 countsByYear W20071449232021 @default.
• W2007144923 countsByYear W20071449232022 @default.
• W2007144923 countsByYear W20071449232023 @default.
• W2007144923 crossrefType "journal-article" @default.
• W2007144923 hasAuthorship W2007144923A5000251765 @default.
• W2007144923 hasAuthorship W2007144923A5001563760 @default.
• W2007144923 hasAuthorship W2007144923A5011398254 @default.
• W2007144923 hasAuthorship W2007144923A5013165857 @default.
• W2007144923 hasAuthorship W2007144923A5024860849 @default.
• W2007144923 hasAuthorship W2007144923A5028807480 @default.
• W2007144923 hasAuthorship W2007144923A5033864294 @default.
• W2007144923 hasAuthorship W2007144923A5040136102 @default.
• W2007144923 hasConcept C126322002 @default.
• W2007144923 hasConcept C142724271 @default.
• W2007144923 hasConcept C150903083 @default.
• W2007144923 hasConcept C16930146 @default.
• W2007144923 hasConcept C171089720 @default.
• W2007144923 hasConcept C190283241 @default.

• next